|
|
| Accelerating Genomic Medicine | Traditional cell therapy manufacturing is hitting a logistical plateau that restricts patient access worldwide. Discover how the concept of the body as a bioreactor could shift the paradigm from external engineering to internal healing. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Cell & Gene: The Podcast | In episode 130 of Cell & Gene: The Podcast, Dr. Naji Gehchan, Chief Medical and Development Officer at Kyverna Therapeutics, joins Host Erin Harris to outline the company’s mission to apply CAR-T cell therapy beyond oncology to treat severe autoimmune diseases, highlighting promising Phase 2 data from its investigational therapy, Miv-cel, in stiff person syndrome (SPS). | |
|
|
| High-Resolution Sizing Methods For Accurate Cell-Free DNA Analysis | Application Note | By Chava Pocernich, Whitney Pike, and Kit-Sum Wong, Agilent Technologies | Discover how precise sizing reveals nucleosome patterns in cfDNA. Learn to isolate genuine biological signals from extraction artifacts to ensure highly reliable genomic data interpretation. |
|
|
|
|
| Bridging Discovery And CMC With Rapid Pools | Webinar | Asimov | Investigate how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how these changes lead to selection. |
|
|
|
| A Strategic Overview Of Fc Engineering | Article | ACROBiosystems | Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges. |
|
|
|
|
|
| Join Chief Editor Erin Harris for a special Cell & Gene Live discussion with Robert Bell, Ph.D., CSO at Ascidian Therapeutics, and Karen Kozarsky, Ph.D., Founder of Vector BioPartners . Together, they'll explore how capsid engineering affects transduction efficiency, the tradeoffs between tissue specificity and manufacturability, and what manufacturing teams need to know about real-world in vivo performance. Register for Solving Vector Yield Challenges in In Vivo CGT on July 7, 2026 at 11 AM ET. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|